Theme lead: Professor Roger A Barker
Roger Barker is the Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at the Addenbrooke’s Hospital Cambridge.
His research seeks to better define the clinical heterogeneity of two common neurodegenerative disorders of the CNS- namely Parkinson’s (PD) and Huntington’s disease (HD). This he has done by collecting large cohorts of incident cases and following them over time using an array of investigational and assessment tools.
In addition he has been heavily involved in gene and cell based trials for patients with these conditions and currently co-ordinates an EU funded transplant programme using human fetal tissue for patients with PD, following on from an earlier MRC funded trial using a similar approach in HD. He is part of a new EU project (NeuroStemCellRepair) and a global initiative (GFORCE-PD) that is seeking to take stem cells to trial in these disorders.
He is currently is Co-Editor in Chief of the Journal of Neurology and sits on the editorial board of many other journals. He has just stepped down as the chairman of the ERC Neuroscience Advanced Grants board, and is on the research advisory board of the Cure PD Trust and Parkinson’s UK.
Theme lead contact details: firstname.lastname@example.org
|Name||Job title||Email address|
|Franklin Aigbirhio||Director of PET (Radiochemistry) Sciences and Professor of Molecular Imaging Chemistryemail@example.com|
|Carol Brayne||Director of Cambridge Institute of Public Healthfirstname.lastname@example.org|
|John O' Brien||Professor of Old Age Psychiatry and Honorary Consultant Psychiatristemail@example.com|
|Trevor Robbins||Professor of Cognitive Neuroscience and Experimental Psychologyfirstname.lastname@example.org|
|James Rowe||Professor, Honorary Consultantemail@example.com|
|David Rubinsztein||Professor of Molecular Neurogeneticsfirstname.lastname@example.org|
|Barbara J Sahakian||Professor of Clinical Neuropsychologyemail@example.com|
|Maria Grazia-Spillantini||Professor of Molecular Neurologyfirstname.lastname@example.org|
|Michel Goedert||Programme Leader, MRC Laboratory of Molecular Biologyemail@example.com|
|Giovanna Mallucci||Mechanisms of firstname.lastname@example.org|
|Anne Bertolotti||Group leader at MRC-LMB, Cambridge, UKemail@example.com|
|David Klenerman||Professor of biophysical chemistry||Dk10012@cam.ac.uk|
|Hugh Markus||Professor of Stroke Medicine||Hsm32@medschl.cam.ac.uk|
|Peter St George Hyslop||Wellcome Trust Principal Research Fellowfirstname.lastname@example.org|
|Caroline Williams-Gray||MRC Clinician Scientistemail@example.com|
|Tim Rittman||Senior Clinical Research Fellowfirstname.lastname@example.org|